European antibiotic awareness day - Why needed?;Europejski Dzień Wiedzy o Antybiotykach - Dlaczego potrzebny?

Polski Merkuriusz Lekarski

Volumn 27, Issue 160, 2009, Pages 261-264

  Hryniewicz, W ^a,b   Mazinska B ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b Zakład Epidemiologii I Mikrobiologii Klinicznej   (Poland)

Author keywords

Antibiotic resistance; Antibiotics; European antibiotic awareness day

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG UTILIZATION; EUROPE; HEALTH PROMOTION; ORGANIZATION AND MANAGEMENT;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; EUROPE; HEALTH PROMOTION;

EID: 72349083739     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Baraniak A., Izdebski R., Herda M. i wsp.: Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland. Antimicrob. Ag. Chemother., 2009, 53, 4565 4567.
2. Boucher H.W., Talbot G.H., Bradley J.S. i wsp.: Bad bugs, no drugs: No ESKAPE! An update from Infectious Diseases Society of America. Clin. Infect Dis., 2009, 48, 1-12.
3. Bronzwaer S.L., Cars O., Buchholz U. i wsp.: European Antimicrobial Resistance Surveillance System. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis., 2002, 8, 278-282.
4. Doi Y., Husain S., Potoski B.A. i wsp.: Extensively drug-resistant Acineto- bacter baumannii. Emerg. Infect. Dis., 2009, 15, 980-982.
5. Duljasz W., Gniadkowski M., Sitter S. i wsp.: First organism with acquired metallo-b-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria. Antimicrob. Ag. Chemother., 2009, 53, 2221-2222.
6. Empel J., Baraniak A., Literacka E. i wsp.: Molecular survey of β-lactamases conferring resistance to newer β-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob. Ag. Chemother., 2008, 52, 2449- 2454.
7. European Antimicrobial Resistance Surveillance System (EARSS). EARSS Annual Report 2007. Bilthoven, The Netherlands: National Institute for Public Health and the Environment, 2008. Available online: http://www.rivm.nl/earss.
8. European Surveillance of Antimicrobial Consumption (ESAC). ESAC Yearbook 2006. Antwerp, Belgium, University of Antwerp, 2008. Available online: http://www.esac.ua.ac.be.
9. Eranshaw S., Monnet D., Duncan B. i wsp.: European Antibiotic Awareness Day: the first Europe wide public information campaign on prudent antibiotic use. Euro surveill., 2009, 14, 19280.
10. Falagas M.E., Karageorgopoulos D.E.: Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram- negative bacilli: need for international harmonization in terminology. Clin. Infect. Dis., 2008, 46, 1121-1122.
11. Fiett J., Baraniak A., Mrówka A. i wsp.: Molecular epidemiology of acquired-metallo-b-lactamase-producing bacteria in Poland. Antimicrob. Ag. Chemother., 2006, 50, 880-886.
12. Gniadkowski M.: Evolution of extended-spectrum beta-lactamases by mutation. Clin. Microbiol. Infect., 2008, 14, supl. 5, 21-24.
13. Leclerq R.: Epidemiological and resistance issues in multidrugs-resistant staphylococci and enterococci. Clinical. Microbiol. Infect., 2009, 15, 224- 231.
14. Lewis H.C., Mollak R., Reese C. i wsp.: Pigs as a source of methicillin- resistant Staphylococcus aureus cc398 infections in humans, Denmark. Emerg. Infect. Dis., 2008, 14, 1383-1389.
15. łuczak-Kadłubowska A., Hryniewicz W.: Opornoś ć na metycylinȩ pozasz- pitalnych szczepów Staphylococcus aureus - nowe zagrozenia. Nowa Klinika, 2006, 13, 726-730.
16. łuczak-Kadłubowska A., Sabat A., Tambic-Andrasevic A. i wsp.: Usefulness of multiple-locus VNTR fingerprinting in detection of clonality of community- and hospital-acquired Staphylococcus aureus isolates. Antonie Van Leeuwenhoek, 2008, 94, 543-553.
17. łuczak-Kadłubowska A., Sulikowska A., Empel J. i wsp.: Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland. J. Clin. Microbiol., 2008, 46, 2930-2937.
18. Maragakis L.L., Perencevich E.N., Cosgrove S.E.: Clinical and economic burden of antimicrobial resistance. Expert. Rev. Anti Infect. Ther., 2008, 6, 751-763.
19. Marcel J.P., Alfa M., Baquero F. i wsp.: Healthcare-associated infections: think globally, act locally. Clin. Microbiol. Infect., 2008, 14, 895-907.
20. Matynia B., Mlodzinska E., Hryniewicz W.: Antimicrobial susceptibility patterns of Staphylococcus aureus in Poland obtained by the National Quality Assurance Programme. Clin. Microbiol. Infect., 2005,11, 379-385.
21. Nordmann P., Cuzon G., Naas T.: The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis., 2009, 9, 228-236.
22. Patzer J., Toleman M.A., Deshpande L.M. i wsp.: Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). J. Antimicrob. Chemother., 2004, 53, 451-456.
23. Poirel L., Pitout J.D., Nordmann P.: Carbapenemases: molecular diversity and clinical consequences. Future Microbiol., 2007, 2, 501-512.
24. Queenan A.M., Bush K.: Carbapenemases: the versatile beta-lactamases. Clin. Microbiol. Rev., 2007, 20, 440-458.
25. Shorr A.F.: Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit. Care Med., 2009, 37, 1463-1469.
26. Skoczyńska A., Kadłubowski M., Waśko I. i wsp.: Resistance patterns of selected respiratory tract pathogens in Poland. Clin. Microbiol. Infect., 2007, 13, 377-383.
27. Spellberg B., Guidos R., Gilbert D.: The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin. Infect. Dis., 2008, 46, 155-164.
28. Tacconelli E.: Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings. Curr. Opin. Infect Dis., 2009, 22, 352-358.
29. Werner G., Coque T.M., Hammerum A.M. i wsp.: Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill., 2008, 13, 19046.
30. The Council of European Communities. Council Recommendation of 15 November 2001 on the prudent use of the antimicrobial agents in the human medicine (Text with EEA relevance). Official Journal of the European Communities, 2002/77/EC.